{"id":97826,"date":"2025-12-05T10:49:09","date_gmt":"2025-12-05T10:49:09","guid":{"rendered":"https:\/\/www.europesays.com\/se\/97826\/"},"modified":"2025-12-05T10:49:09","modified_gmt":"2025-12-05T10:49:09","slug":"bygger-vidare-fran-niva-vid-indexrekord-omxs30-03","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/se\/97826\/","title":{"rendered":"BYGGER VIDARE FR\u00c5N NIV\u00c5 VID INDEXREKORD, OMXS30 +0,3%"},"content":{"rendered":"<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">STOCKHOLM (Nyhetsbyr\u00e5n Direkt) Stockholmsb\u00f6rsen inledde fredagen n\u00e5got h\u00f6gre och byggde d\u00e4rmed vidare p\u00e5 torsdagens indexrekord f\u00f6r storbolagsindexet OMXS30.<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Vid 10.15-tiden var OMXS30 upp 0,3 procent till 2.822. Aktier f\u00f6r drygt 3 miljarder kronor hade d\u00e5 omsatts p\u00e5 Stockholmsb\u00f6rsen i sin helhet. Ute p\u00e5 de ledande Europab\u00f6rserna var utvecklingen likartad som i Stockholm.<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Inom OMXS30 avancerade v\u00e4rmeteknikbolaget Nibe och f\u00f6rsvarsbolaget Saab med 3 respektive 2 procent. M\u00e4tteknikbolaget Hexagon tappade d\u00e4remot 1 procent.<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Boliden har sl\u00e4ppt guidning f\u00f6r 2026. Capex f\u00f6r \u00e5ret ber\u00e4knas uppg\u00e5 till 15 miljarder kronor. I samband med beskedet uppgav gruvbolaget \u00e4ven om en positiv eng\u00e5ngspost p\u00e5 0,4 miljarder kronor relaterat till en justerad bed\u00f6mning av utbyten i R\u00f6nnsk\u00e4r. Aktien var upp cirka en halv procent.<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Citi har h\u00f6jt sin rekommendation f\u00f6r lastbilstillverkaren Volvo till k\u00f6p fr\u00e5n neutral. Riktkursen h\u00f6jdes samtidigt till 328 fr\u00e5n 242 kronor. Aktien st\u00e4rktes 2 procent till 293:70 kronor.<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">JP Morgan har s\u00e4nkt sin rekommendation f\u00f6r skogsbolaget SCA till neutral fr\u00e5n \u00f6vervikt. Riktkursen sattes ned 3 kronor till 130 kronor. Aktien sj\u00f6nk knappt 1 procent till 122:50 kronor.<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">P\u00e5 samma tema har Handelsbanken Capital Markets h\u00f6jt sin rekommendation f\u00f6r handelsbolaget Bufab till k\u00f6p fr\u00e5n beh\u00e5ll medan rekommendationen f\u00f6r teknikhandelsf\u00f6retaget OEM g\u00e5r \u00e5t motsatt h\u00e5ll, till beh\u00e5ll fr\u00e5n k\u00f6p. Bufab steg 3 procent medan OEM sattes ned 5 procent.<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Systemair har f\u00e5tt se en riktkursh\u00f6jning med 4 kronor till 112 kronor fr\u00e5n SEB efter torsdagens rapport som skickade upp aktien med 13 procent. SEB h\u00e5ller fast vid sin k\u00f6prekommendation f\u00f6r aktien. Systemair steg drygt 1 procent till 87:70 kronor.<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Forskningsbolaget Cantargia ser ingen skillnad p\u00e5 median\u00f6verlevnaden i fas 1b\/2-studien Trifour vid behandling av trippelnegativ br\u00f6stcancer (TNBC). Studien utv\u00e4rderade l\u00e4kemedelskandidaten nadunolimab. Cantargie avser nu inte driva utvecklingen inom TNBC vidare. Aktien f\u00f6ll med 11 procent.<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Styrelsen i forskningsbolaget Guard Therapeutics har beslutat att inleda en sonderingsprocess kring strategiska alternativ. Det omfattar b\u00e5de att identifiera m\u00f6jliga kandidater f\u00f6r en fusion eller omv\u00e4nt f\u00f6rv\u00e4rv. I slutet av oktober i \u00e5r meddelade Guard Therapeutics att m\u00e5let inte hade uppn\u00e5tts i bolagets fas 2b-studie med RMC-035 och bolaget har beslutat att avbryta all vidare utveckling av RMC-035. Aktien h\u00f6jdes 14 procent.<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Graf: OMXS30 fredagen den 5 december<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\"><a class=\"text-primary-90 underline hover:text-primary-110 hover:no-underline\" rel=\"noopener noreferrer\" target=\"_blank\" href=\"https:\/\/www.europesays.com\/se\/wp-content\/uploads\/2025\/12\/652024601.png\"><img decoding=\"async\" src=\"https:\/\/www.europesays.com\/se\/wp-content\/uploads\/2025\/12\/652024601.png\" alt=\"image\" class=\"rounded-2xl max-w-full\"\/><\/a><\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">K\u00e4lla: Infront<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Magnus Bernet +46 8 5191 7953<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Nyhetsbyr\u00e5n Direkt<\/p>\n","protected":false},"excerpt":{"rendered":"STOCKHOLM (Nyhetsbyr\u00e5n Direkt) Stockholmsb\u00f6rsen inledde fredagen n\u00e5got h\u00f6gre och byggde d\u00e4rmed vidare p\u00e5 torsdagens indexrekord f\u00f6r storbolagsindexet OMXS30.&hellip;\n","protected":false},"author":2,"featured_media":77249,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[65],"tags":[72,70,71,34,31,33,32,30],"class_list":{"0":"post-97826","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-ekonomi","8":"tag-business","9":"tag-economy","10":"tag-ekonomi","11":"tag-se","12":"tag-svenska","13":"tag-sverige","14":"tag-sweden","15":"tag-swedish"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@se\/115666574739422045","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/97826","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/comments?post=97826"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/97826\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media\/77249"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media?parent=97826"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/categories?post=97826"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/tags?post=97826"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}